1 unchanged sentence
Sale of Unregistered Securities.
+Added: On April 1, 2026, the Company issued 80,873 shares of its common stock, $0.00025 par value per share, in connection with the purchase of all the issued and outstanding share capital of a medical device distributor located in the UK.
+Added: The shares were valued at $1,398,666, representing the closing share price per share on the date of issuance.
+Added: The issuance of common stock was made in reliance upon an exemption provided under Section 4(a)(2) of the Securities Act of 1933, as amended.
+Added: For more information, see the discussion under Note 3 - Business Combinations and Asset Acquisitions of the notes to the condensed consolidated financial statements included in Item 1.
+Added: Financial Statements of Part I of this quarterly report on Form 10-Q, which discussion is incorporated herein by reference.
+Added: On May 1, 2026, the Company issued 153,430 shares of its common stock, representing an aggregate value of approximately $2,398,000, to the members of MedTech Concepts LLC in lieu of the third anniversary payment otherwise required under the MedTech Purchase Agreement, dated May 1, 2023, by and among the Company, Kevin Unger, DINZE LLC, and the sole member of DINZE LLC.
+Added: For more information, see the discussion under Note 3 - Business Combinations and Asset Acquisitions of the notes to the condensed consolidated financial statements included in Item 1.
+Added: Financial Statements of Part I of this quarterly report on Form 10-Q, which discussion is incorporated herein by reference.
+Added: The issuance of the common stock was made in reliance upon an exemption provided under Section 4(a)(2) of the Securities Act of 1933, as amended.
Use of Proceeds.
8 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.